NOX-A12 itself, or in synergistic application with the Tyrosine Kinase Inhibitor drug, significantly suppressed the SDF-1 induced cell migration and reduced the leukemia burden in mice to a greater extent [114]. The gene discussed is CXCL12; the disease is leukemia.